Bristol-Myers Squibb Co (LTS:0R1F) 3-Year Book Growth Rate : -5.10% (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Bristol-Myers Squibb Co 3-Year Book Growth Rate?

Bristol-Myers Squibb Co's Book Value per Share for the quarter that ended in Mar. 2024 was $8.15.

During the past 12 months, Bristol-Myers Squibb Co's average Book Value per Share Growth Rate was -2.70% per year. During the past 3 years, the average Book Value per Share Growth Rate was -5.10% per year. During the past 5 years, the average Book Value per Share Growth Rate was 3.70% per year. During the past 10 years, the average Book Value per Share Growth Rate was 8.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Bristol-Myers Squibb Co was 33.60% per year. The lowest was -13.50% per year. And the median was 3.90% per year.

Competitive Comparison of Bristol-Myers Squibb Co's 3-Year Book Growth Rate

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bristol-Myers Squibb Co's 3-Year Book Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's 3-Year Book Growth Rate falls into.

Bristol-Myers Squibb Co 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Bristol-Myers Squibb Co (LTS:0R1F) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Bristol-Myers Squibb Co 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Bristol-Myers Squibb Co (LTS:0R1F) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (LTS:0R1F) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

BMYMP.PFD:USA BMY:USA BMY:Peru BMY:Mexico 1BMY:Italy BRMd:UK BRM:Germany BMYB34:Brazil BMYS:Austria BMY:Argentina

Address

430 East 29th Street, 14th Floor, New York, NY, USA, 10016

Website

https://www.bms.com

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.

Bristol-Myers Squibb Co (LTS:0R1F) Headlines

No Headlines